-- Bpifrance SACA is looking at a potential investment in Sanofi SA’s consumer health unit as it eyes bigger health investments, according to its executive director Jose Gonzalo.Kamala Harris Is Having a Surprise Resurgence as Biden’s Campaign UnravelsThe French state-owned investment firm is in talks with “many funds” about the Sanofi business and may team up with the winning bidder, Gonzalo said at a Thursday briefing in Paris in response to a question on their strategy.
Separately, a sale of Les Laboratoires Servier’s generic drugmaker Biogaran is on hold due to the snap parliamentary elections in France, even though Bpifrance has put in a non-binding bid with BC Partners, Gonzalo said. The business has also drawn potential bidders including Indian drugmakers Torrent Pharmaceuticals Ltd. and Aurobindo Pharma Ltd., Les Echos and L’Informé have reported.
TFSA investors can consider holding quality growth stocks such as Propel Holdings right now and derive outsized gains in the next five years. The post 2 Canadian Growth Stocks I’d Stash in a TFSA for the Long Run appeared first on The Motley Fool Canada.Alvopetro is a small-cap energy stock that offers you a tasty dividend yield of 10.5% in July 2024. Is the dividend stock a good buy? The post Lock In a 10.